chr19-8862883-T-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BS1BS2_Supporting

The NM_001401501.2(MUC16):​c.42979A>G​(p.Thr14327Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,604,718 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.0054 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00098 ( 7 hom. )

Consequence

MUC16
NM_001401501.2 missense

Scores

1
5
9

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 1.39

Publications

4 publications found
Variant links:
Genes affected
MUC16 (HGNC:15582): (mucin 16, cell surface associated) This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. [provided by RefSeq, May 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069482327).
BP6
Variant 19-8862883-T-C is Benign according to our data. Variant chr19-8862883-T-C is described in ClinVar as Benign. ClinVar VariationId is 3033479.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00543 (827/152232) while in subpopulation AFR AF = 0.0165 (687/41526). AF 95% confidence interval is 0.0155. There are 10 homozygotes in GnomAd4. There are 397 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001401501.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC16
NM_001401501.2
MANE Select
c.42979A>Gp.Thr14327Ala
missense
Exon 86 of 93NP_001388430.1A0AAG2UXK0
MUC16
NM_001414686.1
c.43405A>Gp.Thr14469Ala
missense
Exon 87 of 94NP_001401615.1
MUC16
NM_001414687.1
c.42859A>Gp.Thr14287Ala
missense
Exon 83 of 90NP_001401616.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC16
ENST00000397910.8
TSL:5
c.42757A>Gp.Thr14253Ala
missense
Exon 77 of 84ENSP00000381008.2Q8WXI7
MUC16
ENST00000711672.1
c.42943A>Gp.Thr14315Ala
missense
Exon 81 of 88ENSP00000518832.1A0AAA9YHI4
MUC16
ENST00000710609.1
c.42877A>Gp.Thr14293Ala
missense
Exon 80 of 87ENSP00000518375.1A0AA34QW05

Frequencies

GnomAD3 genomes
AF:
0.00540
AC:
821
AN:
152114
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0166
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0116
Gnomad SAS
AF:
0.00373
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00240
AC:
563
AN:
234794
AF XY:
0.00227
show subpopulations
Gnomad AFR exome
AF:
0.0164
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00869
Gnomad FIN exome
AF:
0.0000483
Gnomad NFE exome
AF:
0.000226
Gnomad OTH exome
AF:
0.00104
GnomAD4 exome
AF:
0.000982
AC:
1427
AN:
1452486
Hom.:
7
Cov.:
31
AF XY:
0.00104
AC XY:
753
AN XY:
721378
show subpopulations
African (AFR)
AF:
0.0150
AC:
502
AN:
33386
American (AMR)
AF:
0.00120
AC:
52
AN:
43258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25902
East Asian (EAS)
AF:
0.00950
AC:
375
AN:
39472
South Asian (SAS)
AF:
0.00363
AC:
305
AN:
83930
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52936
Middle Eastern (MID)
AF:
0.000869
AC:
5
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000912
AC:
101
AN:
1107708
Other (OTH)
AF:
0.00145
AC:
87
AN:
60138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
77
153
230
306
383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00543
AC:
827
AN:
152232
Hom.:
10
Cov.:
32
AF XY:
0.00533
AC XY:
397
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0165
AC:
687
AN:
41526
American (AMR)
AF:
0.00164
AC:
25
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0114
AC:
59
AN:
5170
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68014
Other (OTH)
AF:
0.00805
AC:
17
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
46
92
137
183
229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00195
Hom.:
3
Bravo
AF:
0.00549
ESP6500AA
AF:
0.0123
AC:
50
ESP6500EA
AF:
0.000357
AC:
3
ExAC
AF:
0.00257
AC:
311
Asia WGS
AF:
0.00866
AC:
30
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
MUC16-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
19
DANN
Uncertain
1.0
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.40
T
MetaRNN
Benign
0.0069
T
MetaSVM
Benign
-0.75
T
PhyloP100
1.4
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-3.1
D
REVEL
Benign
0.095
Sift
Benign
0.10
T
Sift4G
Pathogenic
0.0
D
Vest4
0.13
MVP
0.23
ClinPred
0.031
T
GERP RS
4.4
gMVP
0.24
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61734967; hg19: chr19-8973559; API